Industry News

XCMG Flagship Mining Trucks Depart for World-Class Simandou Project, Delivering Key Chinese Technology to Global Mining Development

XUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- XCMG Machinery (SHE:000425) has commenced the shipment of its flagship mining trucks from its intelligent manufacturing base inChina. The equipment is destined for the SimFer mine, part of the Simandou iron ore project inGuinea, West Africa, marking a s...

2025-12-08 10:49 1055

CIMC Unveils New Global Brand Logo and Visual Identity System

SHENZHEN, China, Dec. 7, 2025 /PRNewswire/ -- On December 5, 2025, China International Marine Containers (Group) Co., Ltd. (CIMC) unveiled its new brand logo and visual identity system to a global audience. Marking the company's most significant brand upgrade in nearly fifteen years, the launch s...

2025-12-08 10:21 913

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...

2025-12-08 10:08 1000

Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting

NANJING, China, Dec. 7, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) delivered an oral presentation o...

2025-12-08 10:00 855

Traveloka and Singapore Tourism Board launch regional campaign to inspire spontaneous weekend getaways to Singapore

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- Traveloka, Southeast Asia's leading travel platform, and the Singapore Tourism Board (STB) strengthen their partnership with the launch of a new regional marketing campaign targeting young travellers titled 'A World of Experiences Await'. The initiative aim...

2025-12-08 10:00 929

Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale

Fares as Low as HKD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/ -- Cebu Pacific (PSE: CEB), the Philippines' leading carrier, spreads holiday cheer early as it unwraps its 12.12 Super Seat Fest, giving travelers the chance to treat themselves to a well-deserved vacation that they can look f...

2025-12-08 10:00 772

Cebu Pacific Rolls Out an Early Christmas Surprise with 12.12 Seat Sale

Fares as Low as TWD 1 MANILA, Philippines, Dec. 8, 2025 /PRNewswire/ -- Cebu Pacific (PSE: CEB), the Philippines' leading carrier, spreads holiday cheer early as it unwraps its 12.12 Super Seat Fest, giving travelers the chance to treat themselves to a well-deserved vacation that they can look f...

2025-12-08 10:00 656

Inspur Showcases Modular Construction Capability in Brisbane as Demand for Faster, Scalable Delivery Grows

Industry Leaders Examine Compliance Pathways, AI-Enabled Delivery Models, and Practical Strategies for Deploying Modular Projects Across Australia BRISBANE, Australia, Dec. 8, 2025 /PRNewswire/ -- On December 5, 2025, Shandong Inspur Intelligent Building Technology Co., Ltd. ("Inspur Intelligent ...

2025-12-08 10:00 1117

IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH

SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceuticalcompany focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignanc...

2025-12-08 09:57 757

ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-12-08 09:02 1046

Federation secures prestigious Victorian International Education Award wins

BALLARAT, Australia, Dec. 8, 2025 /PRNewswire/ -- Federation University Australia is the type of university where students feel seen, supported and set up for success. Their campuses stretch acrossVictoria - from the welcoming regional communities of Ballarat and Gippsland to Berwick andMelbourne...

2025-12-08 09:01 884

Daesang Group's "Vietnam Scholarship Quiz Show" Advances Youth Talent Development Through Respect

* Record participation as over 100,000 students nationwide compete in Vietnam's premier academic quiz show * Hanoi student Đinh Bảo Khánh earns top honor, receives a 200 million VND scholarship SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Daesang Group announced that the "Vietnam Scholar...

2025-12-08 09:00 809

TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- TenPay Global, Tencent's cross-border payment platform, and Mastercard Move, Mastercard's money movement business, have announced a collaboration to facilitate fast, secure and transparent digital remittances directly toWeixin Pay, a leading mobile payment ...

2025-12-08 09:00 1411

Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- The Dulwich College Ranjit Murugason Sustainability Fund is pleased to announce renewed support from LGT Bank Singapore ("LGT"), reinforcing a three-year collaboration that has helped Dulwich College (Singapore) students develop the skills, confidence and ...

2025-12-08 09:00 1366

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximatelyJPY 70 million (USD 460,0001) for the development of a prototype detection test for mpox (formerly known as monkeypox2). Mpox is a viral infectious disease that h...

2025-12-08 09:00 865

Global Times: Mogao Caves' mural paintings meet modern technology

BEIJING, Dec. 7, 2025 /PRNewswire/ -- The flying Apsaras dance across the heavens; caravan bells echo along ancient routes. Dunhuang, a pivotal hub on the ancient Silk Road, served as a crossroads where diverse civilizations converged, giving birth to the radiant splendor of the Mogao Caves. As a...

2025-12-08 08:48 666

CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting

SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...

2025-12-08 08:15 875

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health Sciences Authority (HSA) for its 1Bio™AI-Acute toolbox as a Class B software-as-a-medical device (SaMD). The solution is designed to support healthcare pro...

2025-12-08 08:00 920

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ChemLex , a next-generation AI-for-science company, today announced the establishment of its global headquarters and self-driving laboratory inSingapore, alongside the close of aUSD 45 million funding round led by Granite Asia

2025-12-08 08:00 1142

ProstACT Global Phase 3 Update: First Patient Dosed in Randomized Treatment Expansion, Part 1 Readout Plans Confirmed

MELBOURNE, Australia and INDIANAPOLIS, Dec. 8, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the first patient has been dosed in Part 2 (randomized treatment expansion) of its ProstACT Global Phase 3 study evaluating its lead prostate can...

2025-12-08 06:08 737
1 ... 20212223242526 ... 5405

Week's Top Stories